Found: 20
Select item for more details and to access through your institution.
Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early‐stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 6, p. 881, doi. 10.1111/ejh.14093
- By:
- Publication type:
- Article
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.124.267789
- By:
- Publication type:
- Article
Dual-Tracer PET/CT Protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1683, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [ <sup>18</sup>F]-FDG and [ <sup>68</sup>Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [<sup>18</sup>F]-FDG and [<sup>68</sup>Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.122.263835
- By:
- Publication type:
- Article
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 207, doi. 10.2967/jnumed.118.210047
- By:
- Publication type:
- Article
Dual-tracer PET/CT protocol with [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [<sup>18</sup>F]FDG in different cancer types, resulting in larger functional and gross tumor volume.
- Published in:
- Strahlentherapie und Onkologie, 2024, v. 200, n. 1, p. 28, doi. 10.1007/s00066-023-02117-2
- By:
- Publication type:
- Article
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
- By:
- Publication type:
- Article
How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 3, doi. 10.1007/s00259-023-06389-9
- By:
- Publication type:
- Article
Influences on PET Quantification and Interpretation.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 2, p. 451, doi. 10.3390/diagnostics12020451
- By:
- Publication type:
- Article
Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. e5, doi. 10.1111/bjh.17997
- By:
- Publication type:
- Article
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prostataspezifisches Membranantigen (PSMA)‐exprimierende Melanommetastasen bei einem Patienten mit Prostatakarzinom und Melanom: Prostate‐specific membrane antigen (PSMA)‐expressing melanoma metastases in a patient with prostate cancer and melanoma
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 3, p. 446, doi. 10.1111/ddg.15323_g
- By:
- Publication type:
- Article
Prostate‐specific membrane antigen (PSMA)‐expressing melanoma metastases in a patient with prostate cancer and melanoma.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2024, v. 22, n. 3, p. 446, doi. 10.1111/ddg.15323
- By:
- Publication type:
- Article
Fritz Kahn and the Centenary of The Doctor of the Future.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1786, doi. 10.1001/jama.2024.6041
- By:
- Publication type:
- Article
FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 601, doi. 10.3390/cancers12030601
- By:
- Publication type:
- Article